$HIPH Could Rise 5x From Current Levels. If HIPH’s quarterly revenue run-rate reaches our $2M in annual sales target this year it could reach the $0.0125 level, which is similar to other CBD-infused product companies. This target could double in a year’s time as sales in 2021 could reach $5-7M with 20% EBITDA margins https://www.goldmanresearch.com/202002131270/...-2020.html